(Q37800132)

23 August 2017

title

Review: sporadic cerebral amyloid angiopathy (English)

1 reference

23 August 2017

J Attems

1

1 reference

23 August 2017

K Jellinger

series ordinal

2

1 reference

23 August 2017

D R Thal

series ordinal

3

1 reference

23 August 2017

W Van Nostrand

series ordinal

4

1 reference

23 August 2017

publication date

1 February 2011

1 reference

Neuropathology and Applied Neurobiology

23 August 2017

published in

1 reference

23 August 2017

volume

37

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

75-93

1 reference

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Alzheimer disease and cerebrovascular pathology: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral microbleeds: a guide to detection and interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Lymphatic drainage of the brain and the pathophysiology of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Variable deposition of amyloid beta-protein (A beta) with the carboxy-terminus that ends at residue valine40 (A beta 40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specifi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

N-terminal heterogeneity of parenchymal and cerebrovascular Abeta deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy in the elderly: vessel walls changes and relationship with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Thickening of the basement membrane of cortical capillaries in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy in dementia and old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Relationships in Alzheimer's disease between the extent of Abeta deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Clinical manifestations of cerebral amyloid angiopathy-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy in the aged

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Capillary and arterial cerebral amyloid angiopathy in Alzheimer's disease: defining the perivascular route for the elimination of amyloid beta from the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

The distribution of cerebrovascular amyloid in Alzheimer's disease varies with ApoE genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Two types of sporadic cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Dyshoric capillary cerebral amyloid angiopathy mimicking Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

The "nonamyloidogenic" p3 fragment (amyloid beta17-42) is a major constituent of Down's syndrome cerebellar preamyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Apolipoprotein E protects cultured pericytes and astrocytes from D-Abeta(1-40)-mediated cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Role of cerebral amyloid angiopathy in intracerebral hemorrhage in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy: an autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Matrix metalloproteinase 2 (MMP-2) degrades soluble vasculotropic amyloid-beta E22Q and L34V mutants, delaying their toxicity for human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Matrix metalloproteinase-9 in cerebral-amyloid-angiopathy-related hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Matrix metalloproteinases and their multiple roles in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Metalloproteinases in biology and pathology of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Matrix metalloproteinase-9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Bleeding in the brain: Amyloid-beta may keep clots away

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Increased severity of hemorrhage in transgenic mice expressing cerebral protease nexin-2/amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Protease nexin-II (amyloid beta-protein precursor): a platelet alpha-granule protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Superficial siderosis: associations and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Superficial siderosis of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Superficial siderosis: a potential diagnostic marker of cerebral amyloid angiopathy in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Superficial siderosis in the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Superficial siderosis: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Vascular pathology in the aged human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

MRI evidence of past cerebral microbleeds in a healthy elderly population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Types of cerebrovascular lesions associated with severe cerebral amyloid angiopathy in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Relationships between arteriosclerosis, cerebral amyloid angiopathy and myelin loss from cerebral cortical white matter in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Reversible leukoencephalopathy associated with cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Reversible acute leukoencephalopathy as a form of presentation in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Familial British dementia with amyloid angiopathy: early clinical, neuropsychological and imaging findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Vascular pathologies and cognition in a population-based cohort of elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Amyloid angiopathy-related vascular cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Analysis of cerebral amyloid angiopathy in a transgenic mouse model of Alzheimer disease using in vivo multiphoton microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Dementia in cerebral amyloid angiopathy: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Clinical phenotypes of Cerebral Amyloid Angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Reversible leukoencephalopathy in cerebral amyloid angiopathy presenting as subacute dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Is there pure vascular dementia in old age?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Imaging of amyloid burden and distribution in cerebral amyloid angiopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Current state and future directions of neurochemical biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral microvascular amyloid beta protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid beta precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Early-onset subicular microvascular amyloid and neuroinflammation correlate with behavioral deficits in vasculotropic mutant amyloid beta-protein precursor transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Progression of amyloid pathology to Alzheimer's disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Accumulation of beta-amyloid fibrils in pancreas of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Extracellular deposits of A beta produced in cultures of Alzheimer disease brain vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

In vitro production of beta-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

The participation of interleukin-6 in the pathogenesis of alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Beta-amyloid formation by myocytes of leptomeningeal vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Pathophysiology of the lymphatic drainage of the central nervous system: Implications for pathogenesis and therapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Mechanisms to explain the reverse perivascular transport of solutes out of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Abeta-degrading enzymes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Adult mouse astrocytes degrade amyloid-beta in vitro and in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

What is the blood-brain barrier (not)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Occurrence and co-localization of amyloid beta-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2990.2010.01137.X

10.1111/J.1365-2990.2010.01137.X

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference